|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Giving the Sick a Chance for Help, Hope
Fensterman details his experiences as a cancer clinical trial participant in order to galvanize reforms that can help patients get better access to cutting edge treatments. He argues that the increasing lack of trial participants can be traced to the great expenses and hardships inherent in navigating the clinical trial enrollment process. Reforming the system, he contends, will attract more participants and help researchers speed more effective treatments onto the market.
I'm lucky. I live close to major research centers. My doctor leads many trials and knows of others. My employer was unusually supportive. I possess sufficient moxie to advocate for myself. And I do have that insurance. Missing even one of these characteristics might doom my chances.
|home spotlight commentary research events news about contact links archives|